Sachem Capital Corp.
Sachem Capital Corp. (SACH-PA) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Sachem Capital Corp. (SACH-PA), featuring income statements, balance sheets, and cash flow data.
Sachem Capital Corp. (SACH-PA) Income Statement & Financial Overview
Analyze Sachem Capital Corp.’s SACH-PA earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $11.44M | -$23.85M | $14.79M | $15.15M |
| Cost of Revenue | $0.00 | $479000.00 | $290000.00 | $94826.00 |
| Gross Profit | $11.44M | -$24.32M | $14.49M | $15.05M |
| Gross Profit Ratio | $1.00 | $1.02 | $0.98 | $0.99 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.35M | $3.81M | $2.30M | $2.62M |
| Operating Expenses | $10.41M | -$23.85M | $19.61M | $2.62M |
| Total Costs & Expenses | $10.41M | -$23.85M | $19.61M | $2.62M |
| Interest Income | $0.00 | $7.34M | $11.42M | $11.75M |
| Interest Expense | $0.00 | $6.52M | $6.84M | $6.97M |
| Depreciation & Amortization | $0.00 | $91000.00 | $92000.00 | $94826.00 |
| EBITDA | $1.03M | -$29.57M | $0.00 | $0.00 |
| EBITDA Ratio | $0.09 | $1.24 | $0.00 | $0.00 |
| Operating Income | $1.03M | -$29.57M | -$4.82M | $0.00 |
| Operating Income Ratio | $0.09 | $1.24 | -$0.33 | $0.00 |
| Other Income/Expenses (Net) | -$1.24M | -$6.56M | -$229000.00 | -$3.06M |
| Income Before Tax | -$213000.00 | -$36.13M | -$5.05M | -$3.06M |
| Income Before Tax Ratio | -$0.02 | $1.52 | -$0.34 | -$0.20 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$213000.00 | -$36.13M | -$5.05M | -$3.06M |
| Net Income Ratio | -$0.02 | $1.52 | -$0.34 | -$0.20 |
| EPS | -$0.005 | $0.11 | -$0.13 | -$0.09 |
| Diluted EPS | -$0.005 | $0.15 | -$0.13 | -$0.09 |
| Weighted Avg Shares Outstanding | $46.78M | $46.97M | $47.34M | $47.50M |
| Weighted Avg Shares Outstanding (Diluted) | $44.24M | $46.97M | $47.34M | $47.50M |
The company's financials show resilient growth, with revenue advancing from $15.15M in Q2 2024 to $11.44M in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 99% in Q2 2024. Operating income hit $1.03M last quarter, sustaining a consistent 9% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.03M. Net income rose to -$213000.00, while earnings per share reached -$0.005. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan